Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantation
Crossref DOI link: https://doi.org/10.1007/s00277-014-2229-3
Published Online: 2014-10-14
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Koren-Michowitz, Maya
Maayan, Hannah
Apel, Arie
Shem-Tov, Noga
Yerushalmi, Ronit
Volchek, Yulia
Avigdor, Abraham
Shimoni, Avichai
Nagler, Arnon
Text and Data Mining valid from 2014-10-14